• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN SPIDER RX; TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN SPIDER RX; TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Hematoma (1884); Myocardial Infarction (1969); Obstruction/Occlusion (2422); Pseudoaneurysm (2605); Restenosis (4576)
Event Date 06/29/2020
Event Type  Injury  
Manufacturer Narrative
Journal article title: hemodynamic changes between different anatomically designed stents after carotid stenting: a prospective mult icentre study journal of neurology (2020) 267:3392¿3399 https://doi.Org/10.1007/s00415-020-10032-0.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The journal article reported 411 patients enrolled into the multi-center study and divided into two stenting groups of straight carotid stenting (scs) and tapered carotid stenting(tcs).Medtronic devices used in both study groups are the spider fx embolic protection device and protege rx self-expanding stent.Patients who underwent the scs and tcs procedures developed bradycardia within 24 h.In both procedures, patients developed hypotension within 24 h.Complications and 12-month outcomes in both procedures reported are one patient developed acute occlusion of the stent in the scs procedure, and this patient developed a disabling stroke and died 3 weeks post procedure.Six and seven patients who underwent the scs and tcs procedures experienced chs, respectively, and recovered within the short-term; these patients received a ct scan that showed no evidence of thromboembolism or new stroke.Four and six pat ients developed post procedure hypertension after the scs and tcs procedures, respectively.Access-site complications were detected in 9 scs patients and 12 tcs patients.Two patients suffered disabling stroke after the scs procedure, 4 patients suffered non-disabling stroke, and 4 patients suffered disabling stroke after the tcs procedure at 12 months.One patient had an mi, and one patient died following the scs procedure.Hematoma and psuedoaneurysm adverse events were also reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPIDER RX
Type of Device
TEMPORARY CAROTID CATHETER FOR EMBOLIC CAPTURE
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12031214
MDR Text Key257120696
Report Number2183870-2021-00215
Device Sequence Number1
Product Code NTE
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K063204
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/28/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age65 YR
Patient Weight69
-
-